N@N

Celldex Therapeutics to Host Corporate 2010 Year-End and 2011 Objectives Update Call

_{//health-fitness.news-articles.net/content/2011/ .. 10-year-end-and-2011-objectives-update-call.html}
^{Published in Health and Fitness on Thursday, February 24th 2011 at 6:10 GMT by Market Wire}  

NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (NASDAQ: CLDX) will host a conference call before U.S. financial markets open at 8:30 a.m. Eastern Time on Thursday, March 3, 2011, to provide a year-end summary for 2010 and an update on anticipated research and development and business objectives for 2011.

The conference call will be webcast live over the Internet and can be accessed by logging on to the Events Calendar under the "News & Events" section of the Celldex Therapeutics website at [ www.celldextherapeutics.com ]. The call can also be accessed by dialing 888-713-4218 (within the United States) or 617-213-4870 (outside the United States). The passcode for participants is 68508575.

A replay of the call will be available approximately two hours after the live call concludes through March 17, 2011. To access the replay, dial 888-286-8010 (within the United States) or 617-801-6888 (outside the United States). The passcode is 18594660. The webcast will also be archived on the Companya™s website.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].